Results 61 to 70 of about 2,533,979 (187)

Long-term outcomes of amniotic membrane treatment in acute Stevens-Johnson syndrome/toxic epidermal necrolysis.

open access: yesThe ocular surface, 2020
PURPOSE To report the long-term outcomes of amniotic membrane (AM) use in the form of transplantation (AMT) and self-retained amniotic membrane (ProKera® device, PD) in acute Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN).
S. Shanbhag   +3 more
semanticscholar   +1 more source

Stevens-Johnson Syndrome Following Treatment With Carbamazepine for a Mood Disorder [PDF]

open access: yes, 2012
A case of Stevens-Johnson Syndrome (SJS) induced by carbamazepine in a psychiatric patient with schizo-affective disorder is reported. The patient also had diabetes mellitus and was on glyburide which posed an initial dilemma at the onset of SJS as to ...
Coleman, Albert, M.D., M.P.H.   +1 more
core   +1 more source

Ocular Manifestations of Stevens-Johnson Syndrome [PDF]

open access: yes, 2021
The purpose of this case report was to have a further study of the proper management of ocular manifestations caused by Stevens-Johnson Syndrome, which aims to minimize the chances of complications. This case report will discuss the ocular manifestations
Doemillah, Ratna   +1 more
core   +2 more sources

A case report of Stevens-Johnson syndrome and toxic epidermal necrolysis due to diclofenac sodium [PDF]

open access: yes, 2020
Stevens-Johnson syndrome (SJS) is a severe skin reaction most often triggered by particular drugs in most of the cases. A more severe form of the condition is called toxic epidermal necrolysis (TEN) which involves more than 30% of the skin surface and ...
Bendi, Sreenivasa Rao   +1 more
core   +2 more sources

Stevens-Johnson syndrome induced by phenytoin: a case report [PDF]

open access: yes, 2016
Stevens-Johnson syndrome (SJS) and Toxic epidermal necrolysis (TEN) are rare (one to two per 10,00,00 population per year) but life threatening adverse drug reactions.
Bhanu, Lalkota Prakash   +4 more
core   +2 more sources

Pharmacogenomic testing and its future in community pharmacy [PDF]

open access: yes, 2020
Although it is common to see pharmacogenomic testing used North America and Australia, it is not yet part of practice in the UK. With the promise of genomic screening becoming part of the NHS, pharmacists must equip themselves with a knowledge of how the
Wright, David, Youssef, Essra
core   +1 more source

British Association of Dermatologists' guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in children and young people, 2018

open access: yesBritish Journal of Dermatology, 2019
The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the diagnosis and management of the full spectrum of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and SJS-TEN overlap in children (0 ...
T. McPherson   +33 more
semanticscholar   +1 more source

Acute middle ear Aspergillus niger infection in a patient with Stevens-Johnson syndrome: a case report

open access: yesJournal of Acute Disease, 2019
Rationale: Stevens-Johnson syndrome is a disorder mostly attributed to drug use, which can cause different skin problems. Patient concerns: A 31-year-old woman presented with severe pain and pounding in the left ear.
Keyvan Kiakojuri   +5 more
doaj   +1 more source

Skin reactions probably attributed to the use of phenytoin and vancomycin [PDF]

open access: yesEinstein (São Paulo), 2008
Cutaneous reactions are the most common adverse events attributed to medications. Stevens-Johnson syndrome or erythema multiforme is a severe and acute reaction determined by medications, especially aspirin, phenytoin, and vancomycin.
Carla Tozato   +2 more
doaj  

Risk of Stevens-Johnson Syndrome with AEDs

open access: yesPediatric Neurology Briefs, 1995
An international case-controlled study of medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis is reported by the Groupe Epidemiologie LY Stevens Johnson (ELYS), Department of Dermatology, and Department of Public Health,
J Gordon Millichap
doaj   +1 more source

Home - About - Disclaimer - Privacy